1. Anticancer Res. 2004 May-Jun;24(3b):1861-71.
Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E, Tsuboi K, Saijo K, Harada H, Takano S, Nose T, Ohno T.

2. Neurosurg Focus. 2000 Dec 15;9(6):e9.
Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.
Sloan AE , Dansey R , Zamorano L , Barger G , Hamm CDiaz F , Baynes R , Wood G .

3. BJU Int. 2003 Dec;92(9):1009-15.
Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.
Oikawa T , Kawai K , Ishiwata I , Ohno T , Akaza H .

4. World J Gastroenterol. 2004 Jul 15;10(14):2119-23.
Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
Peng BG , Liang LJ , He Q, Huang JF , Lu MD .

5. World J Gastroenterol. 2002 Jun;8(3):464-8.
Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
Wang FS , Liu MX , Zhang B , Shi M , Lei ZY , Sun WB , Du QY , Chen JM .

6. World J Gastroenterol. 2004 Apr 15;10(8):1146-51.
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.
Shi M , Zhang B , Tang ZR , Lei ZY , Wang HF , Feng YY , Fan ZP , Xu DP , Wang FS .

7. PASRM 2006-001
Autologous Immune Enhancement Therapy (AIET) for a Case of Acute Myeloid Leukemia (AML) - Our Experience..
Sharat Damodar , Terunuma H , Sheriff AK , Farzana L , Manjunath S , Senthilkumar R , Shastikumar G , Abraham S , Wang FS

8. Thermal Med. 2007; 23 (1)
Mild hyperthermia modulates the relative frequency of lymphocyte cell subpopulations: an increase in a cytolytic NK cell subset and a decrease in a regulatory T cell subset
Hiroshi Terunuma, Ayano Wada, Xuewen Deng, Yoshihide Yasuma Tetsuro Onishi, Atsushi Toki, Hiroyuki Abe

9. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections
Hiroshi Terunuma, Xuewen Deng, Zahidunnabi Dewan, Shigeyoshi Fujimoto, and Naoki Yamamoto

10. Peritoneal Carcinomatosis 2007
Immunotherapy of Peritoneal Carcinomatosis
Michael A. Strohlein and Markus M. Heiss

11. Nature Reviews; immunology May2007; 7
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren and Karl-Johan Malmberg

12. The Journal of Immunology, 2007, 178: 4011-4016.
NK cells and Cancer
Loris Zamai, Cristina Ponti, Prisco Mirandola, Giuliana Gobbi, Stefano Papa, Laura Galeotti, Lucio Cocco and Marco Vitale

13. Drug News Perspect 2007, 20(3): 155
NK Cell-Based Cancer Immunotherapy
John Stagg and Mark J. Smyth

14. Expert Opinion on Biological Therapy, May 2007; Volume 7, ( 5): 599-615
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Ainhoa Arina, Oihana Murillo, Juan Dubrot, Arantza Azpilikueta, Carlos Alfaro, Jose L. Perez-Gracia, Maurizio Bendandi, Belen Palencia, Sandra Hervas-Stubbs & Ignacio Melero

15. Anti-cancer Drugs 2007; 18: 597-604
Chemoimmunotherapy in the treatment of metastatic gastric cancer
Francesco Recchia, Gaetano Saggio, Giampiero Candeloro, Alisis Cesta, Giovanna Amiconi, Anna Di Blasio, Stefano Necozione and Silvio Rea

16. PASRM 2006-001
Autologous Immune Enhancement Therapy (AIET) for a Case of Acute Myeloid Leukemia (AML) - Our Experience.
Sharat Damodar , Terunuma H , Sheriff AK , Farzana L , Manjunath S , Senthilkumar R , Shastikumar G , Abraham S , Wang FS

17. Cytotherapy 2006; 8 (2): 93-9
Commentry- Cytotoxic lymphocytes for clinic
AJ Barrett and JG Sharp

18. Annals of Surgical Oncology 2005; 12 (12): 1005-1016
Tumor Regression and Autoimmunity in Patients treated with Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade and Interleukin 2: A phase I/II Study
Ajay V.Maker, Giao Q.Phan, Peter Attia, James C.Yang, Richard M.Sherry, Suzanne L.Topalian, Udai S.Kammula, Richard E.Royal, Leah R.Haworth, Catherine Levy, David Kleiner, Sharon A.Mavroukakis, Michael Yellin, Steven A.Rosenberg

19. Clinical Advances in Hematology & Oncology 2005; 3
Cell Transfer and Other Immunotherapeutic Strategies
Mark J. Ratain.

20. Anticancer Research 2005; 25: 3709-3714
Efficacy of immuno-cell Therapy in patients with Advanced Pancreatic Cancer
Toru Kaneko, Shigenori Goto, Akira Kato, Akiteru Akeyama, Masamichi Tomonaga, Katsunada Fujimoto, Yoju Miyamoto, Masazumi Eriguchi, and Koji Egawa

21. Anticancer Research 2005; 25: 3741-3746
Combined Immunocell Therapy Using Activated Lymphocytes and Monocyte-derived Dendritic Cells for Malignant Melanoma
Shigenori Goto, Toru Kaneko, Yoju Miyamoto, Masazumi Eriguchi, Akira Kato, Teruhisa Akeyama, Katsuhiro Fujimoto, Masamichi Tomonaga, and Koji Egawa

22. Nature Clinical Practice Oncology March 2005; 2 (3)
Cancer immunotherapy comes of age
Steven A Rosenberg

23. World J Gastroenterol. 2004 Jul 15;10(14):2119-23.
Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
Peng BG , Liang LJ , He Q, Huang JF , Lu MD .

24. World J Gastroenterol. 2002 Jun;8(3):464-8.
Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
Wang FS , Liu MX , Zhang B , Shi M , Lei ZY , Sun WB , Du QY , Chen JM

25. N ENGL J MED 2004; 350 14 April 1
Shedding light on Immunotherapy for Cancer
Steven A. Rosenberg, M. D. PhD.

26. Anticancer Research 2004; 24: 3303-3310
A Report of Three Patients Treated with Immunocell Therapy with Imatinib Mesylate
Toru Kaneko, Shigenori Goto, Kohji Egawa, Yoju Miyamoto, Msazumi Eriguchi, Yoshiaki Kushima, Mie Nieda

27. Anticancer Research 2004; 24: 3321-3326
Immuno-cell therapy of Cancer in Japan
Kohji Egawa

28. J Am Coll Surg 2004; 198 (5)
Development of Effective Immunotherapy for the Treatment of Patients with Cancer
Steven A. Rosenberg, MD, PhD.

29. PNAS 2004 October 5; 101: 14639-14645
Cancer Regression in patients with metastatic melanoma after the transfer of autologous lymphocytes
Steven A Rosenberg and Mark E. Dudley

30. Int. J. Cancer 2003; 105: 512-519
Tumor-Loocalization by Adoptively Transferred, Interleukin-2-Activated NK Cells Leads to Destruction of well-Established Lung Metastases
Qin Yang, Marianne E. Hokland, John L. Bryant, Yuquing Zhang, Ulf Nannmark, Simone C. Watkins, Ronald H. Goldfarb, Ronald B. Herberman, Per H. Basse

31. B J U International 2003
Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer
T. Oikawa, K. Kawai, I. Ishiwata, T. Ohno, and H. Akaza

32. Anticancer Research 2002; 22:2461-2464
Clinical Benefit of Non-Toxic Therapy in Patients with Advanced Cancer (Opinion)
Shigenori Goto, Noriko Shirotani, Masahiko Hatakeyama, Chieko Tagami, Hiroko Arakawa, Eri Kuwata, Katsuo Noguchi, Kohji Egawa

33. Neurosurg. Focus 2000; 9 (6)
Adoptive immunotherapy in patients with recurrent malignant glioma preliminary results of using autologous whole-tumor vaccine plus granulocyte macrophage colony stimulating factor and adoptive transfer of anti-CD3 activated lymphocytes
Andrew E. Sloan, Roger Dansey, Lucia Zamorano, Med, Geoffrey Barger, Caroline Hamm, Fernando Diaz, Roy Baynes, and Gary Wood

34. Tranfusion Science 2000; 23: 133-150
Adoptive allogeneic immunotherapy-history and future perspectives Michael Schleuning

35. Int J Oncol 2000; 17(6): 1107-1118
Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer.
K. Araki, Y Noguchi, T Hirouchi, E Yoshikawa, S Kataoka, L Silverni, H Miyazawa, H Kuzuhara, C Suzuki, Y Shimada, S Hamasato, N Maeda, Y Shimamura, Y Ogawa, Y Ohtsuki, S Fujimoto